419 related articles for article (PubMed ID: 16394556)
1. In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid).
Gao P; Ding P; Xu H; Yuan Z; Chen D; Wei J; Chen D
Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):89-93. PubMed ID: 16394556
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of huperzine A from biodegradable microspheres: In vitro and in vivo studies.
Gao P; Xu H; Ding P; Gao Q; Sun J; Chen D
Int J Pharm; 2007 Feb; 330(1-2):1-5. PubMed ID: 16987624
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro and in vivo release studies of Huperzine A loaded microspheres for the treatment of Alzheimer's disease.
Liu WH; Song JL; Liu K; Chu DF; Li YX
J Control Release; 2005 Oct; 107(3):417-27. PubMed ID: 16154224
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vivo evaluation of huperzine A-loaded PLGA microspheres.
Fu XD; Gao YL; Ping QN; Ren T
Arch Pharm Res; 2005 Sep; 28(9):1092-6. PubMed ID: 16212243
[TBL] [Abstract][Full Text] [Related]
5. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers.
Elkheshen SA; Radwan MA
J Microencapsul; 2000; 17(4):425-35. PubMed ID: 10898083
[TBL] [Abstract][Full Text] [Related]
6. Poly(lactic-co-glycolic acid) microspheres for the controlled release of huperzine A: in vitro and in vivo studies and the application in the treatment of the impaired memory of mice.
Chu D; Tian J; Liu W; Li Z; Li Y
Chem Pharm Bull (Tokyo); 2007 Apr; 55(4):625-8. PubMed ID: 17409558
[TBL] [Abstract][Full Text] [Related]
7. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
[TBL] [Abstract][Full Text] [Related]
8. Preparation of poly(D,L-lactide) and copoly(lactide-glycolide) microspheres of uniform size.
Shiga K; Muramatsu N; Kondo T
J Pharm Pharmacol; 1996 Sep; 48(9):891-5. PubMed ID: 8910847
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable bromocryptine mesylate microspheres prepared by a solvent evaporation technique. I: Evaluation of formulation variables on microspheres characteristics for brain delivery.
Arica B; Kaş HS; Orman MN; Hincal AA
J Microencapsul; 2002; 19(4):473-84. PubMed ID: 12396384
[TBL] [Abstract][Full Text] [Related]
10. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition.
Lück M; Pistel KF; Li YX; Blunk T; Müller RH; Kissel T
J Control Release; 1998 Nov; 55(2-3):107-20. PubMed ID: 9795026
[TBL] [Abstract][Full Text] [Related]
11. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres.
Fu X; Ping Q; Gao Y
J Microencapsul; 2005 Feb; 22(1):57-66. PubMed ID: 16019891
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
Kwon YM; Kim SW
Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
[TBL] [Abstract][Full Text] [Related]
13. [Effect of preparation technique on in vitro release mechanism of huperzine A microspheres].
Fu XD; Gao YL; Ping QN
Yao Xue Xue Bao; 2006 Jul; 41(7):589-94. PubMed ID: 17007348
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs.
Chu DF; Fu XQ; Liu WH; Liu K; Li YX
Int J Pharm; 2006 Nov; 325(1-2):116-23. PubMed ID: 16876971
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics.
Bittner B; Morlock M; Koll H; Winter G; Kissel T
Eur J Pharm Biopharm; 1998 May; 45(3):295-305. PubMed ID: 9653634
[TBL] [Abstract][Full Text] [Related]
17. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
Uchida T; Goto S; Foster TP
J Pharm Pharmacol; 1995 Jul; 47(7):556-60. PubMed ID: 8568620
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
Jiang G; Qiu W; DeLuca PP
Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA.
Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
Pharm Res; 1999 Apr; 16(4):509-13. PubMed ID: 10227704
[TBL] [Abstract][Full Text] [Related]
20. Ketotifen-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers: characterization and in vivo evaluation.
Guerrero S; Muñíz E; Teijón C; Olmo R; Teijón JM; Blanco MD
J Pharm Sci; 2008 Aug; 97(8):3153-69. PubMed ID: 18023014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
